Xenetic
1D
1W
1M
3M
YTD
1Y
5Y
ALL
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell Xenetic and other ETFs, options, and stocks.About XBIO
Xenetic Biosciences, Inc. is a biopharmaceutical company engaged in the advancement of cell-based therapeutics to target the B-cell receptor on the surface of an individual patient’s malignant tumor cells. Its product pipeline includes XCart Platform and Polyxen.
CEOJeffrey F. Eisenberg
CEOJeffrey F. Eisenberg
Employees4
Employees4
HeadquartersFramingham, Massachusetts
HeadquartersFramingham, Massachusetts
Founded2011
Founded2011
Employees4
Employees4
XBIO Key Statistics
Market cap6.01M
Market cap6.01M
Price-Earnings ratio-1.47
Price-Earnings ratio-1.47
Dividend yield—
Dividend yield—
Average volume6.65K
Average volume6.65K
High today$3.90
High today$3.90
Low today$3.90
Low today$3.90
Open price$3.90
Open price$3.90
Volume1.35K
Volume1.35K
52 Week high$5.97
52 Week high$5.97
52 Week low$2.55
52 Week low$2.55
XBIO News
TipRanks 5d
Xenetic Biosciences, Inc. Under Pressure: Shareholder Activism Threatens Stability and Financial Future - TipRanks.com - TipRanksXenetic Biosciences, Inc. (XBIO) has disclosed a new risk, in the Share Price & Shareholder Rights category. Xenetic Biosciences, Inc. faces financial risks fr...
Yahoo Finance 6d
Xenetic Biosciences, Inc. Reports Full Year 2023 Financial Results - Yahoo FinanceContinued advancement of DNase-based oncology program towards Phase 1 clinical study for the treatment of pancreatic carcinoma and other locally advanced or met...